Schedule 13G ownership disclosure

RAPT THERAPEUTICS INC

Common Stock $0.0001 par value per share · CUSIP: 75382E109

Event date: 2024-12-23

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Deep Track Capital, LP

    Shares: 14,116,000.00 · Class: 9.87%

  • Deep Track Biotechnology Master Fund, Ltd.

    Shares: 14,116,000.00 · Class: 9.87%

  • David Kroin

    Shares: 14,116,000.00 · Class: 9.87%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001172661-24-005417
Form type
SCHEDULE 13G
Filer
Deep Track Capital, LP
CIK
CIK 1856083
Filed
Dec 23, 2024
Reporting period
Dec 23, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub